|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0681 - 0.0730|
|52 Week Range||0.0500 - 1.2400|
|Beta (3Y Monthly)||3.62|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Beleave will add roughly 100,000 sq. ft. for cannabis extraction, processing, and cultivation. Toronto, Ontario--(Newsfile Corp. - May 23, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is ready to move forward with the long-awaited expansion of its Hamilton facility after receiving approval from the Hamilton City Council.Last Tuesday, the Planning Committee unanimously authorized Beleave's request to rezone the Hamilton facility and allowed the application to proceed forward to last ...
TORONTO, May 15, 2019 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to provide an update on its meeting with the Hamilton Planning Committee on May 14, 2019. The committee unanimously approved Beleave's request to rezone their facility in Hamilton, Ontario and will reconvene later this month, through a city council meeting the week of May 20, 2019, to finalize the approval for expansion. Beleave's Hamilton facility continues to provide high-efficiency extraction, R&D, product development and cultivation of cannabis and cannabis derived products throughout this approval process.
TORONTO , May 7, 2019 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that the Hamilton Planning Committee will consider the Company's upcoming Hamilton facility expansion plans during a public meeting to be held on May 14, 2019 . The Hamilton facility houses growing space for Beleave's line of cannabis products, and continues to be its main hub for extraction, packaging, and distribution.
TORONTO, April 8, 2019 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that its wholly-owned subsidiary Beleave Kannabis Corp has commenced sales of cannabis oil products at its licensed facility in Hamilton, Ontario. Beleave has completed its first wholesale transfer of two bulk lots of cannabis oil to another standard processor license holder, as well as having begun cannabis oil product sales to medicinal patients through its online store https://shop.beleave.com. The Company received authorization from Health Canada to sell cannabis oil products in January 2019.
TORONTO, April 5, 2019 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that it has received a Building Permit and moved forward in the Health Canada Licensing process for its facility in London, Ontario. In September 2018, Beleave purchased the existing 250,000 sq. ft. greenhouse facility and has since been developing the property. This includes the installation of 10 megawatts of electrical capacity fully serviced by London Hydro, HVAC, equipment, and site engineering exceeding industry standards.
TORONTO , March 4, 2019 /CNW/ - Beleave (CSE:BE) (BLEVF) ("Beleave" or the "Company") announces that it released the Company's Interim Condensed Consolidated Financial Statements for the third quarter for the three and nine months ended December 31, 2018 , together with its Management, Discussion and Analysis ("MD&A") on March 1, 2019 . All amounts in this news release and the Company's financial disclosures are in Canadian dollars, except per share amounts or as indicated otherwise. The Company's accounting policies are in accordance with IFRS.
James (Jim) Wasserstrom : A native of New York , Jim has extensive international experience and expertise in governance, compliance and internal control. Jim spent the early part of his career in various corporate capacities, including as a global partnerships executive for American Express Travel Related Services. In 2002, Jim led the United Nations operation overseeing Kosovo's public utilities representing $4 billion in assets transforming many into modern and profitable businesses. From 2009-2014, Mr. Wasserstrom led the US effort to combat corruption for the United States Government in Afghanistan , engaging extensively with the military, and international organizations and governments.
TORONTO, Feb. 12, 2019 /PRNewswire/ - Medi-Green, a wholly-owned subsidiary of Beleave (BE.CN) (BLEVF) ("Beleave" or the "Company") is excited to invite the community to the grand opening event of its new clinic in London, Ontario this Friday, February 15, 2019. "We are very excited to expand our Medi-Green family into the London region and continue to provide a comforting and encouraging environment for patients seeking medical cannabis as a form of treatment," said Ashleigh Koeslag, Operations Manager. During the event, staff from Medi-Green will be present to answer questions and share information about cannabis and the clinic's services with attendees.
TORONTO , Jan. 31, 2019 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that its wholly-owned subsidiary, Beleave Kannabis Corporation, has obtained ISO 9001:2015 Certification for the research, development, and production of cannabis products for medicinal and recreational purposes at its Hamilton, Ontario facility. ISO 9001 is a quality management system standard developed by the International Organization for Standardization, an association of governmental and nongovernmental organizations from many countries. ISO 9001:2015 is the most up-to-date standard of its kind and contains key updates, including an emphasis on risk-based thinking to enhance the application of the process approach, improved applicability for services, and increased leadership requirements.
TORONTO , Jan. 17, 2019 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to provide an update on its participation and cooperation regarding the ongoing investigation by the British Colombia Securities Commission ("BCSC"). As previously announced, Beleave was named as a respondent in a temporary order dated November 26, 2018 (the "Temporary Order") issued by the Executive Director of the BCSC in connection with distributions to certain individuals connected to the "BridgeMark Group". The Executive Director of the BCSC sought an extension of the Temporary Order (the "Extension Request") pending the conclusion of the BCSC's investigation into the Respondents' reliance on the Consultant Exemption.
TORONTO , Jan. 16, 2019 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") announces that Bill Panagiotakopoulos , current COO at Beleave, has been appointed by the Board of Directors to act as the Executive Chairman to further strengthen Beleave's governance and oversight controls. As one of the Company's founding members in 2011, Bill was an early mover in Canada's cannabis sector. Since then, Bill has been significantly involved in the successful navigation of the regulatory framework to obtain cannabis production and sales licenses.
TORONTO, Jan. 15, 2019 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is excited to announce its wholly-owned subsidiary Beleave Kannabis Corp. has been authorized by Health Canada to sell cannabis oil products effective January 11, 2019. After reviewing the application and supporting documentation, Health Canada granted an amended licence with modified conditions allowing for the sale of cannabis oil under the Cannabis Regulations. "This license is pivotal to us meeting our goals in 2019, while driving product innovation and augmenting our research and development initiatives," said Roger Ferreira, Ph.D., Beleave's Chief Science Officer.